Fluoropharma Medical Stock Market Value

FPMI Stock  USD 0.0002  0.00  0.00%   
Fluoropharma Medical's market value is the price at which a share of Fluoropharma Medical trades on a public exchange. It measures the collective expectations of Fluoropharma Medical investors about its performance. Fluoropharma Medical is trading at 2.0E-4 as of the 2nd of January 2026. This is a No Change since the beginning of the trading day. The stock's open price was 2.0E-4.
With this module, you can estimate the performance of a buy and hold strategy of Fluoropharma Medical and determine expected loss or profit from investing in Fluoropharma Medical over a given investment horizon. Check out Fluoropharma Medical Correlation, Fluoropharma Medical Volatility and Fluoropharma Medical Alpha and Beta module to complement your research on Fluoropharma Medical.
Symbol

Please note, there is a significant difference between Fluoropharma Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fluoropharma Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fluoropharma Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Fluoropharma Medical 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Fluoropharma Medical's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Fluoropharma Medical.
0.00
07/11/2024
No Change 0.00  0.0 
In 1 year 5 months and 25 days
01/02/2026
0.00
If you would invest  0.00  in Fluoropharma Medical on July 11, 2024 and sell it all today you would earn a total of 0.00 from holding Fluoropharma Medical or generate 0.0% return on investment in Fluoropharma Medical over 540 days. FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of... More

Fluoropharma Medical Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Fluoropharma Medical's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Fluoropharma Medical upside and downside potential and time the market with a certain degree of confidence.

Fluoropharma Medical Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Fluoropharma Medical's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Fluoropharma Medical's standard deviation. In reality, there are many statistical measures that can use Fluoropharma Medical historical prices to predict the future Fluoropharma Medical's volatility.
Hype
Prediction
LowEstimatedHigh
0.000.000112.60
Details
Intrinsic
Valuation
LowRealHigh
0.000.000212.60
Details
Naive
Forecast
LowNextHigh
0.0000040.000212.60
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.00020.00020.0002
Details

Fluoropharma Medical Backtested Returns

Fluoropharma Medical is out of control given 3 months investment horizon. Fluoropharma Medical secures Sharpe Ratio (or Efficiency) of 0.13, which denotes the company had a 0.13 % return per unit of risk over the last 3 months. We have collected data for sixteen different technical indicators, which can help you to evaluate if expected returns of 1.59% are justified by taking the suggested risk. Use Fluoropharma Medical Variance of 151.52, standard deviation of 12.31, and Mean Deviation of 2.98 to evaluate company specific risk that cannot be diversified away. Fluoropharma Medical holds a performance score of 10 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of 1.7, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Fluoropharma Medical will likely underperform. Use Fluoropharma Medical standard deviation, as well as the relationship between the maximum drawdown and day median price , to analyze future returns on Fluoropharma Medical.

Auto-correlation

    
  0.00  

No correlation between past and present

Fluoropharma Medical has no correlation between past and present. Overlapping area represents the amount of predictability between Fluoropharma Medical time series from 11th of July 2024 to 7th of April 2025 and 7th of April 2025 to 2nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Fluoropharma Medical price movement. The serial correlation of 0.0 indicates that just 0.0% of current Fluoropharma Medical price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0

Fluoropharma Medical lagged returns against current returns

Autocorrelation, which is Fluoropharma Medical pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Fluoropharma Medical's pink sheet expected returns. We can calculate the autocorrelation of Fluoropharma Medical returns to help us make a trade decision. For example, suppose you find that Fluoropharma Medical has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Fluoropharma Medical regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Fluoropharma Medical pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Fluoropharma Medical pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Fluoropharma Medical pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Fluoropharma Medical Lagged Returns

When evaluating Fluoropharma Medical's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Fluoropharma Medical pink sheet have on its future price. Fluoropharma Medical autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Fluoropharma Medical autocorrelation shows the relationship between Fluoropharma Medical pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Fluoropharma Medical.
   Regressed Prices   
       Timeline  

Currently Active Assets on Macroaxis

Other Information on Investing in Fluoropharma Pink Sheet

Fluoropharma Medical financial ratios help investors to determine whether Fluoropharma Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fluoropharma with respect to the benefits of owning Fluoropharma Medical security.